Respiratory Tract Infection Testing
Virant Diagnostics Respiratory Tract Infection (RTI) panel allows quick identification of causative pathogens, prompting faster targeted clinical decisions, leading to better patient outcomes.
At Virant Diagnostics, we use gold standard PCR technology to genetically identify upper respiratory pathogens. Our panels provide significantly faster, more specific and accurate results in comparison to traditional culture.`
Create Orders
Create orders using Provider Portal or Test Requisition Form
Follow specimen collection and handling instructions
Resources
Visit Resources Page for more details
Respiratory Tract Infection Test Menu
- Influenza A
- Influenza B
- RSV (respiratory syncytial virus)
- SARS-CoV-2
- Adenovirus
- Enterovirus
- Human metapneumovirus
- Influenza A (Pan)
- Influenza B
- Rhinovirus
- RSV A/B (respiratory syncytial virus)
- SARS-CoV-2
- Chlamydia pneumoniae
- Haemophilus influenzae
- Klebsiella pneumoniae
- Legionella pneumophila
- Moraxella catarrhalis
- Mycoplasma pneumoniae
- Staphylococcus aureus
- Streptococcus pneumoniae
Why Choose RTI Testing with Virant Diagnostics?
Our expert scientists and technicians have an efficient workflow supplemented with advanced PCR technology to guarantee results within 24 hours. Most results will be reported the same day. Our staff physicians understand the value of these PCR-based panels because they result in better patient outcomes.
- Faster reports means that targeted antivirals or antibiotics can be initiated sooner, if medication is even necessary
- avoid unnecessary side effects with common, but potentially irrelevant “broad-spectrum” medications
- prevent complications
- promote and enhance responsible antibiotic stewardship
- More specificity means a higher degree of certainty:
- less confusion of similar-appearing cultures, if the pathogen can even be cultured
- less errors, less complications, therefore better patient outcomes